Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Response to Anti-EGFR Therapy in Patients with BRAF non-V600-Mutant Metastatic Colorectal Cancer.

Yaeger R, Kotani D, Mondaca S, Parikh AR, Bando H, Van Seventer EE, Taniguchi H, Zhao H, Thant CN, de Stanchina E, Rosen N, Corcoran RB, Yoshino T, Yao Z, Ebi H.

Clin Cancer Res. 2019 Sep 12. doi: 10.1158/1078-0432.CCR-19-2004. [Epub ahead of print]

PMID:
31515458
2.

Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers.

Parikh AR, Leshchiner I, Elagina L, Goyal L, Levovitz C, Siravegna G, Livitz D, Rhrissorrakrai K, Martin EE, Van Seventer EE, Hanna M, Slowik K, Utro F, Pinto CJ, Wong A, Danysh BP, de la Cruz FF, Fetter IJ, Nadres B, Shahzade HA, Allen JN, Blaszkowsky LS, Clark JW, Giantonio B, Murphy JE, Nipp RD, Roeland E, Ryan DP, Weekes CD, Kwak EL, Faris JE, Wo JY, Aguet F, Dey-Guha I, Hazar-Rethinam M, Dias-Santagata D, Ting DT, Zhu AX, Hong TS, Golub TR, Iafrate AJ, Adalsteinsson VA, Bardelli A, Parida L, Juric D, Getz G, Corcoran RB.

Nat Med. 2019 Sep;25(9):1415-1421. doi: 10.1038/s41591-019-0561-9. Epub 2019 Sep 9.

PMID:
31501609
3.

Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse events.

Badran YR, Cohen JV, Brastianos PK, Parikh AR, Hong TS, Dougan M.

J Immunother Cancer. 2019 Aug 22;7(1):226. doi: 10.1186/s40425-019-0711-0.

4.

Lung Cancer Genomics.

Parikh AR.

Acta Med Acad. 2019 Apr;48(1):78-83. doi: 10.5644/ama2006-124.244.

5.

POETIC (Program for Enhanced Training in Cancer): An Initial Experience of Supporting Capacity Building for Oncology Training in Sub-Saharan Africa.

Fish M, Parkes J, Dharsee N, Dryden-Peterson S, Efstathiou J, Schnipper L, Chabner B, Parikh AR.

Oncologist. 2019 Jun 10. pii: theoncologist.2019-0207. doi: 10.1634/theoncologist.2019-0207. [Epub ahead of print]

PMID:
31182656
6.

Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical Trial.

Murphy JE, Wo JY, Ryan DP, Clark JW, Jiang W, Yeap BY, Drapek LC, Ly L, Baglini CV, Blaszkowsky LS, Ferrone CR, Parikh AR, Weekes CD, Nipp RD, Kwak EL, Allen JN, Corcoran RB, Ting DT, Faris JE, Zhu AX, Goyal L, Berger DL, Qadan M, Lillemoe KD, Talele N, Jain RK, DeLaney TF, Duda DG, Boucher Y, Fernández-Del Castillo C, Hong TS.

JAMA Oncol. 2019 Jul 1;5(7):1020-1027. doi: 10.1001/jamaoncol.2019.0892.

PMID:
31145418
7.

Pencil Beam Scanning Proton Beam Chemoradiation Therapy With 5-Fluorouracil and Mitomycin-C for Definitive Treatment of Carcinoma of the Anal Canal: A Multi-institutional Pilot Feasibility Study.

Wo JY, Plastaras JP, Metz JM, Jiang W, Yeap BY, Drapek LC, Adams J, Baglini C, Ryan DP, Murphy JE, Parikh AR, Allen JN, Clark JW, Blaszkowsky LS, DeLaney TF, Ben-Josef E, Hong TS.

Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):90-95. doi: 10.1016/j.ijrobp.2019.04.040. Epub 2019 May 22.

PMID:
31128146
8.

Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy.

Parikh AR, He Y, Hong TS, Corcoran RB, Clark JW, Ryan DP, Zou L, Ting DT, Catenacci DV, Chao J, Fakih M, Klempner SJ, Ross JS, Frampton GM, Miller VA, Ali SM, Schrock AB.

Oncologist. 2019 Apr 30. pii: theoncologist.2019-0034. doi: 10.1634/theoncologist.2019-0034. [Epub ahead of print]

PMID:
31040255
9.

Long-term outcomes in myelodysplastic syndrome patients treated with alemtuzumab.

Lai C, Ranpura V, Wu C, Olnes MJ, Parikh AR, Shenoy A, Thompson J, Weinstein B, Scheinberg P, Barrett AJ, Desmond R, Young NS, Hourigan CS.

Blood Adv. 2019 Apr 9;3(7):980-983. doi: 10.1182/bloodadvances.2018030411. No abstract available. Erratum in: Blood Adv. 2019 Jun 11;3(11):1657.

10.

High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy.

Mitra D, Horick NK, Brackett DG, Mouw KW, Hornick JL, Ferrone S, Hong TS, Mamon H, Clark JW, Parikh AR, Allen JN, Ryan DP, Ting DT, Deshpande V, Wo JY.

Oncologist. 2019 Jun;24(6):e275-e283. doi: 10.1634/theoncologist.2018-0794. Epub 2019 Feb 12.

PMID:
30755500
11.

Enrichment of HER2 Amplification in Brain Metastases from Primary Gastrointestinal Malignancies.

Mitra D, Clark JW, Shih HA, Oh KS, Brastianos PK, Wo JY, Strickland MR, Curry WT, Parikh AR, Corcoran RB, Ryan DP, Iafrate AJ, Borger DR, Lennerz JK, Hong TS.

Oncologist. 2019 Feb;24(2):193-201. doi: 10.1634/theoncologist.2018-0152. Epub 2018 Oct 29.

PMID:
30373904
12.

MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer.

Parikh AR, Lee FC, Yau L, Koh H, Knost J, Mitchell EP, Bosanac I, Choong N, Scappaticci F, Mancao C, Lenz HJ.

Clin Cancer Res. 2019 May 15;25(10):2988-2995. doi: 10.1158/1078-0432.CCR-18-1221. Epub 2018 Sep 17.

PMID:
30224341
13.

Liver reirradiation for patients with hepatocellular carcinoma and liver metastasis.

McDuff SGR, Remillard KA, Zheng H, Raldow AC, Wo JY, Eyler CE, Drapek LC, Goyal L, Blaszkowsky LS, Clark JW, Allen JN, Parikh AR, Ryan DP, Ferrone CR, Tanabe KK, Wolfgang JA, Zhu AX, Hong TS.

Pract Radiat Oncol. 2018 Nov - Dec;8(6):414-421. doi: 10.1016/j.prro.2018.04.012. Epub 2018 Apr 26.

PMID:
29937235
14.

Response to rapamycin analogs but not PD-1 inhibitors in PTEN-mutated metastatic non-small-cell lung cancer with high tumor mutational burden.

Parikh AR, Ali SM, Schrock AB, Albacker LA, Miller VA, Stephens PJ, Crilley P, Markman M.

Lung Cancer (Auckl). 2018 May 18;9:45-47. doi: 10.2147/LCTT.S161738. eCollection 2018.

15.

Primary tumor sidedness is an independent prognostic marker for survival in metastatic colorectal cancer: Results from a large retrospective cohort with mutational analysis.

Kamran SC, Clark JW, Zheng H, Borger DR, Blaszkowsky LS, Allen JN, Kwak EL, Wo JY, Parikh AR, Nipp RD, Murphy JE, Goyal L, Zhu AX, Iafrate AJ, Corcoran RB, Ryan DP, Hong TS.

Cancer Med. 2018 May 17. doi: 10.1002/cam4.1558. [Epub ahead of print]

16.

Chronic softening spinal cord stimulation arrays.

Garcia-Sandoval A, Pal A, Mishra AM, Sherman S, Parikh AR, Joshi-Imre A, Arreaga-Salas D, Gutierrez-Heredia G, Duran-Martinez AC, Nathan J, Hosseini SM, Carmel JB, Voit W.

J Neural Eng. 2018 Aug;15(4):045002. doi: 10.1088/1741-2552/aab90d. Epub 2018 Mar 23.

PMID:
29569573
17.

Convergent Therapeutic Strategies to Overcome the Heterogeneity of Acquired Resistance in BRAFV600E Colorectal Cancer.

Hazar-Rethinam M, Kleyman M, Han GC, Liu D, Ahronian LG, Shahzade HA, Chen L, Parikh AR, Allen JN, Clark JW, Kwak EL, Faris JE, Murphy JE, Hong TS, Van Seventer EE, Nadres B, Hong CB, Gurski JM Jr, Jessop NA, Dias-Santagata D, Iafrate AJ, Van Allen EM, Corcoran RB.

Cancer Discov. 2018 Apr;8(4):417-427. doi: 10.1158/2159-8290.CD-17-1227. Epub 2018 Feb 5.

18.

Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer.

Strickler JH, Loree JM, Ahronian LG, Parikh AR, Niedzwiecki D, Pereira AAL, McKinney M, Korn WM, Atreya CE, Banks KC, Nagy RJ, Meric-Bernstam F, Lanman RB, Talasaz A, Tsigelny IF, Corcoran RB, Kopetz S.

Cancer Discov. 2018 Feb;8(2):164-173. doi: 10.1158/2159-8290.CD-17-1009. Epub 2017 Dec 1.

19.

Monitoring resistance through liquid biopsy.

Parikh AR, Corcoran RB.

Ann Oncol. 2018 Jan 1;29(1):8-11. doi: 10.1093/annonc/mdx650. No abstract available.

20.

Prognostic Significance of Surgical Margin Size After Neoadjuvant FOLFOX and/or FOLFIRI for Colorectal Liver Metastases.

Miller CL, Taylor MS, Qadan M, Deshpande V, Worthington S, Smalley R, Collura C, Ryan DP, Allen JN, Blaszkowsky LS, Clark JW, Murphy JE, Parikh AR, Berger D, Tanabe KK, Lillemoe KD, Ferrone CR.

J Gastrointest Surg. 2017 Nov;21(11):1831-1840. doi: 10.1007/s11605-017-3557-0. Epub 2017 Sep 7.

PMID:
28884391
21.

Fast-TRKing Drug Development for Rare Molecular Targets.

Parikh AR, Corcoran RB.

Cancer Discov. 2017 Sep;7(9):934-936. doi: 10.1158/2159-8290.CD-17-0704.

22.

Medical Oncologists' Experiences in Using Genomic Testing for Lung and Colorectal Cancer Care.

Gray SW, Kim B, Sholl L, Cronin A, Parikh AR, Klabunde CN, Kahn KL, Haggstrom DA, Keating NL.

J Oncol Pract. 2017 Mar;13(3):e185-e196. doi: 10.1200/JOP.2016.016659. Epub 2017 Jan 17.

23.

Oncologists' Selection of Genetic and Molecular Testing in the Evolving Landscape of Stage II Colorectal Cancer.

Parikh AR, Keating NL, Liu PH, Gray SW, Klabunde CN, Kahn KL, Haggstrom DA, Syngal S, Kim B.

J Oncol Pract. 2016 Mar;12(3):e308-19, 259-60. doi: 10.1200/JOP.2015.007062.

24.

Incidence and clinical significance of ESR1 mutations in heavily pretreated metastatic breast cancer patients.

Niu J, Andres G, Kramer K, Kundranda MN, Alvarez RH, Klimant E, Parikh AR, Tan B, Staren ED, Markman M.

Onco Targets Ther. 2015 Nov 11;8:3323-8. doi: 10.2147/OTT.S92443. eCollection 2015.

25.

Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug.

Desmond R, Townsley DM, Dumitriu B, Olnes MJ, Scheinberg P, Bevans M, Parikh AR, Broder K, Calvo KR, Wu CO, Young NS, Dunbar CE.

Blood. 2014 Mar 20;123(12):1818-25. doi: 10.1182/blood-2013-10-534743. Epub 2013 Dec 17.

26.

Ductal carcinoma in situ: knowledge of associated risks and prognosis among Latina and non-Latina white women.

Parikh AR, Kaplan CP, Burke NJ, Livaudais-Toman J, Hwang ES, Karliner LS.

Breast Cancer Res Treat. 2013 Sep;141(2):261-8. doi: 10.1007/s10549-013-2676-x. Epub 2013 Sep 1.

27.

Immunomodulatory treatment of myelodysplastic syndromes: antithymocyte globulin, cyclosporine, and alemtuzumab.

Parikh AR, Olnes MJ, Barrett AJ.

Semin Hematol. 2012 Oct;49(4):304-11. doi: 10.1053/j.seminhematol.2012.07.004. Review.

28.

Eltrombopag and improved hematopoiesis in refractory aplastic anemia.

Olnes MJ, Scheinberg P, Calvo KR, Desmond R, Tang Y, Dumitriu B, Parikh AR, Soto S, Biancotto A, Feng X, Lozier J, Wu CO, Young NS, Dunbar CE.

N Engl J Med. 2012 Jul 5;367(1):11-9. doi: 10.1056/NEJMoa1200931. Erratum in: N Engl J Med. 2012 Jul 19;367(3):284.

29.

Superallowed Gamow-Teller decay of the doubly magic nucleus 100Sn.

Hinke CB, Böhmer M, Boutachkov P, Faestermann T, Geissel H, Gerl J, Gernhäuser R, Górska M, Gottardo A, Grawe H, Grębosz JL, Krücken R, Kurz N, Liu Z, Maier L, Nowacki F, Pietri S, Podolyák Z, Sieja K, Steiger K, Straub K, Weick H, Wollersheim HJ, Woods PJ, Al-Dahan N, Alkhomashi N, Ataç A, Blazhev A, Braun NF, Čeliković IT, Davinson T, Dillmann I, Domingo-Pardo C, Doornenbal PC, de France G, Farrelly GF, Farinon F, Goel N, Habermann TC, Hoischen R, Janik R, Karny M, Kaşkaş A, Kojouharov IM, Kröll T, Litvinov Y, Myalski S, Nebel F, Nishimura S, Nociforo C, Nyberg J, Parikh AR, Procházka A, Regan PH, Rigollet C, Schaffner H, Scheidenberger C, Schwertel S, Söderström PA, Steer SJ, Stolz A, Strmeň P.

Nature. 2012 Jun 20;486(7403):341-5. doi: 10.1038/nature11116.

PMID:
22722192
30.

Synthesis, antitubercular evaluation and 3D-QSAR study of N-phenyl-3-(4-fluorophenyl)-4-substituted pyrazole derivatives.

Khunt RC, Khedkar VM, Chawda RS, Chauhan NA, Parikh AR, Coutinho EC.

Bioorg Med Chem Lett. 2012 Jan 1;22(1):666-78. doi: 10.1016/j.bmcl.2011.10.059. Epub 2011 Oct 30.

PMID:
22104148
31.

Suicidal ideation associated with duloxetine use: a case series.

Parikh AR, Thatcher BT, Tamano EA, Liskow BI.

J Clin Psychopharmacol. 2008 Feb;28(1):101-2. doi: 10.1097/jcp.0b013e318160d5c3. No abstract available.

PMID:
18204351
32.

Diagnostic fine-needle aspiration in postoperative wound infections is more accurate at predicting causative organisms than wound swabs.

Parikh AR, Hamilton S, Sivarajan V, Withey S, Butler PE.

Ann R Coll Surg Engl. 2007 Mar;89(2):166-7.

33.

Manic delirium associated with clomiphene-induced ovulation.

Parikh AR, Liskow BI.

Psychosomatics. 2007 Jan-Feb;48(1):65-6. No abstract available.

PMID:
17209152
34.

A portal to validated websites on cosmetic surgery: the design of an archetype.

Parikh AR, Kok K, Redfern B, Clarke A, Withey S, Butler PE.

Ann Plast Surg. 2006 Sep;57(3):350-2.

PMID:
16929210
35.

Plastic surgery and the undergraduate medical school curriculum.

Parikh AR, Clarke A, Butler PE.

Med Educ. 2006 May;40(5):476-7. No abstract available.

PMID:
16635148
36.

Knee dislocation with ipsilateral femoral shaft fracture: a report of five cases.

Giannoudis PV, Roberts CS, Parikh AR, Agarwal S, Hadjikouti-Dyer C, Macdonald DA.

J Orthop Trauma. 2005 Mar;19(3):205-10.

PMID:
15758676
38.
39.

Management of severe hemorrhagic cystitis in pregnancy. A report of two cases.

Fakhoury GF, Daikoku NH, Parikh AR.

J Reprod Med. 1994 Jun;39(6):485-8.

PMID:
7932406
40.

Extramammary Paget's disease of the scrotum: need for early biopsy.

Parikh AR, Aghazarian SG, Orbegoso CM, Schirmer HK.

South Med J. 1986 Jun;79(6):779-80.

PMID:
3012788

Supplemental Content

Loading ...
Support Center